Pharmacological evaluation of substituted 4, 5-diphenyl furan-3-carboxamide compound for antidepressant activity in mice


  • Jayakumar J. K. Department of Pharmacology, Sambhram Institute of Medical Sciences and Research, Kolar Gold Fields, Kolar, Karnataka, India
  • . Nityakarnam Department of Pharmacology, Adhiparasakthi Institute of Medical Sciences and Research, Tamilnadu, India
  • Kishore Kumar P. Department of Pharmacology, PES Institute of Medical Sciences and Research, Kuppam, Andhra Pradesh, India
  • . Supriya Department of Pharmacology, Sri Sai Dental College and Research Institute, Srikakulam, Andhra Pradesh, India



Antidepressant activity, FST, Novel furan compound, TST


Background: Depressive disorder is a prevalent psychiatric disorder, which affects 21% of the world population. Many drugs are available as effective antidepressants. But still there is necessity of developing novel compounds with minimized side effects. Hence this study was aimed to investigate the antidepressant activity of novel furan compound in albino mice.

Methods: Antidepressant activity of novel furan compound was investigated by using forced swimming test (FST) and tail suspension test (TST) models. Fluoxetine was used as standard drug in this study.

Results: It has been observed from our study that medium dose of test compound (10 mg/kg) reduced duration of immobility time to 35 seconds when compared to control group (147 seconds) in FST model. In TST model, the test compound of medium dose (10 mg/kg) had produced 83% protection against passive behaviour which is almost similar to standard drug fluoxetine (100%).

Conclusions: The results of the specifies that compared to other two doses of test compound (5 mg/kg and 20 mg/kg), medium dose of test compound found as an effective dose for treating depression produced due to stress. However, further expansion of the study is needed for this compound to prove as a novel effective antidepressant compared to other drugs available for treating depression.


Sindhu T, Mamatha A, Sahith Reddy K, Venkateshwarlu K. Antidepressant activity of pyrimidine derivatives in mice. J Drug Med. 2013;5:129-34.

Riyaz M, Kumar A, Raj V, Singh S. Review on antidepressant activity in behavioral models. Int J pharm Integrated Life Sci. 2013;1(3):16-29.

Dipiro T. Joseph Pharmacotherapy. A Pathophysiological Approach. 6th edition. McGraw-Hill medical publishing division; 2014; 1235-1256.

Baldessarini RJ. Drugs and the treatment of psychiatric disorders: Depression and anxiety disorders. In: Hardman JG, Limbrid LE, Goodman A, et al, editors. Goodman and Gilman’s. The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill; 2000:447-484.

Warner V, Weissman MM, Mufson L, Wickramaratne PJ. Grandparents, parents, and grandchildren at high risk for depression: Three-generation study. J Am Acad Child Adolesc Psychiatry. 1999;38:289-96.

Kendler KS, Prescott CA. A population based twin study of lifetime major depression in men and women. Arch Gen Psychiatry. 1999;56:39-44.

Nutt DJ. Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry. 2008;69:4-7.

Vinayak M, Ruckmani A, Chandrashekar K, Konda VGR, Madhavi E, Swati B. Antidepressant activity of ethanolic extract Piper betle leaves in mice. Curr Res in Neurosci. 2012;2(1):11-6.

Singh GK, Garabadu D, Muruganandam AV, Joshi VK, Krishnamurthy S. Antidepressant activity of Asparagus racemosus in rodent models. Pharmacol Biochem Behav. 2009;91:283-90.

Shoeb A, Chowta M, Pallempati G, Rai A, Singh A. Evaluation of antidepressant activity of vanillin in mice. Indian J Pharmacol. 2013;45(2):141-4.

Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1977;229:327-36.

Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacol (Berl). 1985;85:367-70.

Ahmed Amany AE, Al-Rashed Nawal M, Al-Rasheed Nouf M. Antidepressant-like activities of rosiglitazone in the rat forced swim and the mouse tail suspension tests. Saudi Pharma J. 2009;1(17):51-61.

Plaznik A, Tamborska E, Hauptmann M, Bidzinski A, Kostowski W. Brain neurotransmitter systems mediating behavioral deficits produced by inescapable shock treatment in rats. Brain Res. 1988;447:122-32.

Manavi C, Pinki V, Gautam P. Comparative evaluation of Bacopa monniera and Panax quniquefolium in experimental and depressive models in mice. Indian J Exp Biol. 2010;48:306-31.

Ramana Murty Kadali SLDV, Das MC, Srinivasa Rao ASR, Karuna Sri G. Antidepressant Activity of Brahmi in Albino Mice. J Clin Diagn Res. 2014;8(3):35-7.




How to Cite

J. K., J., Nityakarnam, ., P., K. K., & Supriya, . (2016). Pharmacological evaluation of substituted 4, 5-diphenyl furan-3-carboxamide compound for antidepressant activity in mice. International Journal of Basic & Clinical Pharmacology, 6(1), 39–42.



Original Research Articles